查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840667

全球泌尿系统市场（按产品类型、应用、最终用户、分销管道和技术）预测 2025-2032

Urology Market by Product Type, Application, End User, Distribution Channel, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年泌尿系统市场将成长至 1,298.5 亿美元，复合年增长率为 10.59%。

主要市场统计数据
基准年2024年 580亿美元
预计2025年 642.8亿美元
预测年份：2032年 1298.5亿美元
复合年增长率（%） 10.59%

为不断变化的泌尿系统设备格局、不断变化的临床实践和加速的技术创新提供明确的策略方向

泌尿系统医疗设备市场格局正因临床需求的融合、人口结构趋势和快速的技术创新而重塑。人口老化导致慢性和急性泌尿系统系统疾病的发生率上升，而医疗保健服务模式也正从住院转向门诊。同时，影像技术和微创工具的进步正在改变临床路径和临床医生的期望，迫使医疗保健提供者重新评估其资本配置和筹资策略。

因此，製造商、经销商和医疗系统正在应对一个更复杂的环境，监管审查、感染预防重点和永续性考量交织在一起。付款人和供应商透过以结果为导向的采购和长期服务关係寻求价值，而数位管道正开始改变传统的分销动态。这些因素的共同作用要求对产品系列、通路投资和伙伴关係进行策略性清晰的规划，以便在快速变化的环境中保持临床相关性和商业性绩效。

为什么微创技术、诊断成像的进步、一次性使用和数位化分销正在从根本上改变泌尿系统的临床和商业模式

近年来，泌尿系统产业经历了一场变革，重新定义了产品生命週期、采购方式和病患就诊路径。在先进影像处理和雷射技术的推动下，微创技术正在降低手术干预的阈值，缩短住院时间，并支持手术持续转移到门诊手术中心和门诊。同时，感染控制重点、操作简单性和总医疗成本计算的变化正在加速一次性器材的普及。

同时，数位整合和先进的影像技术正在协助实现更早的诊断和更精准的干预，而人工智慧和先进的视觉化工具也开始影响设备设计和临床工作流程。随着电子商务和医疗直销模式与传统医院采购模式的整合，分销管道也不断调整，从而带来新的竞争压力和定价动态。随着这些转变的持续，那些将设备创新、服务交付和跨职能专业知识与数据主导的临床证据相结合的公司将更有能力抓住机会，并缓解行业快速转型带来的营运和监管阻力。

评估 2025 年美国关税对泌尿系统医疗设备采购、生产、采购和定价动态的广泛营运和策略影响

美国2025年实施的关税变化的累积效应，已在整个泌尿系统器械供应链中产生了一系列新的约束和奖励。依赖进口零件的製造商面临着不断上升的投入成本，这迫使许多製造商重新评估筹资策略，并加快本地化生产或寻找合适的替代供应商。这些调整影响了定价策略、库存政策和供应商合同，促使相关人员重新评估长期供应商关係和合约弹性。

医疗保健提供者和经销商已采取应对措施，加强谈判，优先考虑基于价值的采购，并研究其对包括服务和成本在内的总成本的影响。此外，一些医疗设备製造商正在将高价值的组装和最终测试转移到国内工厂，以减少关税波动带来的影响，并保持更可预测的前置作业时间。日益增长的监管合规和海关复杂性加重了行政负担，从而有利于拥有强大供应链能力的大型公司。总体而言，关税环境正在加速采购、生产布局和贸易条款的结构性调整，促使製造商和负责人做出短期营运应对措施和长期策略重新定位。

详细的细分框架，突显推动临床效用、采购行为和商业策略的产品、应用、最终用户、通路和技术的差异

详细查看细分市场可发现产品、应用、最终用户、分销和技术维度上的差异化需求、临床效用和采购行为。按产品类型，市场细分为抛弃式和可重复使用设备，其中抛弃式设备包括导管和支架。导管进一步细分为Foley导管和间歇导管，支架进一步细分为肾造口支架和输尿管支架。可重复使用器械包括内视镜和手术器械，其中内视镜进一步细分为软式内视镜内视镜和硬式内视镜。这些产品细分与感染控制优先顺序、手术量和资本投资週期密切相关。

治疗应用针对不同的临床驱动因素，例如前列腺增生治疗、癌症诊断、结石去除和尿失禁管理，每种应用都有其独特的临床工作流程、报销考虑和设备性能要求。最终用户包括门诊手术中心、诊所和医院，每家都有自己的采购管治、预算界限和营运限制。分销管道涵盖电子商务、医​​院采购和零售药局，数位管道日益影响着消耗品和小型设备的购买行为。影像技术本身涵盖电脑断层扫描、MRI 和超音波模式，为诊断途径和程序规划提供资讯。了解这些交叉细分市场有助于开发有针对性的产品、制定差异化的销售策略以及根据临床需求和购买者偏好定制的服务模式。

美洲、欧洲、中东和非洲以及亚太地区的区域动态决定了泌尿系统设备的采购、监管参与和供应链弹性

美洲、欧洲、中东和非洲以及亚太地区的区域动态正在塑造竞争重点和投资选择，每个地区都呈现不同的监管、报销和供应链格局。在美洲，私人医疗机构、综合医院系统和门诊手术中心的扩张推动了对缩短手术时间并支持当天出院的设备的需求，同时，分销模式也越来越多地采用直接采购和耗材电商模式。

在欧洲、中东和非洲，采购通常受公共支付方和集中采购机制的影响，成本控制压力与高标准的临床证据和再处理并存，因此可重复使用器械在某些市场仍具有重要意义。在亚太地区，快速的医疗保健投资、不断增长的手术量以及对本地製造能力的重视，正在加速微创技术、影像处理升级和混合分销策略的采用。这些地区差异表明，需要製定区域化的商业策略，积极与监管机构沟通，并根据各地区的监管复杂性、采购成熟度和基础设施发展情况，客製化供应链的弹性。

透过整合优先考虑策略伙伴关係、服务主导的产品供应、整合解决方案、售后服务和扩充性的参与者来增强产业的竞争动态

泌尿系统设备生态系内的竞争态势日益呈现策略多元化、伙伴关係和服务导向经营模式的特征。领先的製造商正在投资捆绑解决方案，将设备与培训、资讯服务和维护合约相结合，以深化客户关係并建立经常性收益来源。设备製造商、影像供应商和临床中心之间的策略合作正在加速检验週期，并支援整合程式解决方案的广泛应用。

同时，规模较小的创新企业正专注于利基市场、一次性替代品以及技术驱动的差异化，以期获得临床关注并吸引分销合作伙伴。寻求在生产、监管专业知识和售后服务能力方面实现规模化的公司正在进行整合，而合约条款和服务水准承诺正成为采购决策的核心考虑因素。在这种环境下，那些将研发重点与明确的临床价值提案和强大的售后支持相结合的公司将更有能力获得持久的合同，并应对不断变化的报销和采购压力。

产业领导者可以采取切实可行的高影响力行动来加强其供应链、推动临床差异化、扩展以服务为导向的商业模式并确保永续成长

为了应对不断变化的市场环境并实现永续成长，产业领导者应追求供应链韧性、临床差异化和商业性敏捷性的结合。首先，实现供应商基础多元化和关键製造流程在地化，将降低关税波动风险并确保前置作业时间。其次，优先考虑那些能够带来可衡量临床和经济效益的产品特性，例如缩短手术时间、降低感染风险和降低总发病成本，这将增强其在註重价值的买家中的采购定位。

第三，围绕设备销售建立服务和培训方案可以提高客户维繫，并创造可预测的收益来源。第四，拓展耗材和低成本医疗设备的数位化和直销诊所销售管道，可以补充传统的医院采购，并加快市场进入。最后，积极与监管机构和付款方沟通临床证据和实际结果，可以支持有利的采用和报销决策。总而言之，这些行动基于营运可靠性、临床相关性和商业性灵活性，建构了可防御的策略态势。

强大的多方法调查方法结合临床文献、监管研究、专家访谈和检验，提供可操作和检验的业界考察

此研究方法融合了多学科投入，以确保分析的严谨性、三角测量和实践相关性。二次研究包括系统性地回顾同侪审查的临床文献、监管备案文件、操作指南和公共文件，以绘製临床路径、技术采用和合规性要求。一次研究包括对临床医生、采购主管、供应链经理和产品开发人员进行结构化访谈，以了解现实世界的营运限制、偏好驱动因素和采用障碍。来自製造商技术文件和产品註册的数据提供了设备规格和功能比较。

我们根据采购方的采购框架和临床专家的意见，对定性洞察检验，以确保其与实践模式和采购理念相符。我们优先考虑调查方法和资料来源的透明度、资料来源的清晰记录，以及由内部跨职能审查和外部专家检验组成的多层次检验流程。限制包括机构采购惯例的多样性以及不断变化的费率和监管指南；我们透过敏感度分析和情境规划来应对这些问题，以发现合理的策略应对措施，而非单一的确定性结果。

最后，我们概述了将泌尿系统技术进步和供应链挑战转化为竞争优势所需的策略重点和紧急行动。

摘要：泌尿系统医疗设备领域正处于曲折点，临床创新、不断变化的采购和供应链压力交织在一起。向微创手术的转变、一次性感染控制产品的兴起以及先进影像处理和雷射技术的整合，正在重塑临床路径和买家期望。同时，关税主导的成本动态以及采购和管理体制的区域差异，迫使企业在采购、定价和商业性参与方面保持敏捷。

未来的成功取决于整合的方法，该方法应将产品开发与明确的临床价值相结合，增强服务和培训能力，并建立供应链韧性。门诊病人转变、投资数位化和分销灵活性，并在临床、监管和商业职能部门之间开展协作的医疗保健提供者和製造商，将占据有利地位，在保持财务和营运稳定的同时，实现患者疗效的改善。现在做出的策略选择将决定谁将在不断变化的格局中获胜。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 技术进步和患者需求导致前列腺和肾臟手术中机器人辅助腹腔镜手术的增加。
  • 透过开发和实施用于前列腺癌早期检测的非侵入性生物标记来改善患者预后
  • 前列腺增生的微创治疗（如前列腺动脉栓塞和水蒸气疗法）的增长
  • 整合远端医疗和远端患者监护平台，用于区域泌尿系统实践中的术后护理
  • 基于精准医疗方法的进行性尿路上皮癌合併标靶治疗和免疫治疗的激增
  • 引进人工智慧诊断影像分析，提高泌尿系统疾病检测的准确性与效率

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章泌尿系统市场（依产品类型）

  • 免洗设备
    • 导管
      • Foley导管
      • 间歇导尿管
    • 支架
      • 肾臟造口支架
      • 输尿管支架
  • 可重复使用的设备
    • 内视镜检查
      • 柔性内视镜
      • 硬式内视镜
    • 手术器械

第九章泌尿系统市场的应用

  • 良性摄护腺增生的治疗
  • 癌症诊断
  • 去除结石
  • 尿失禁管理

第 10 章泌尿系统市场（依最终用户划分）

  • 门诊手术中心
  • 诊所
  • 医院

第 11 章泌尿系统市场通路

  • 电子商务
  • 医院采购
  • 零售药局

第十二章泌尿系统市场（按技术）

  • 成像技术
    • 电脑断层扫描
    • MRI
    • 超音波
  • 雷射技术

第十三章泌尿系统市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章泌尿系统市场：依类别

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章泌尿系统市场（按国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Boston Scientific Corporation
    • Johnson & Johnson
    • Olympus Corporation
    • Medtronic plc
    • Stryker Corporation
    • Coloplast A/S
    • Teleflex Incorporated
    • Becton, Dickinson and Company
    • STERIS plc
    • Baxter International Inc.
Product Code: MRR-0360AB17DF5A

The Urology Market is projected to grow by USD 129.85 billion at a CAGR of 10.59% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 58.00 billion
Estimated Year [2025] USD 64.28 billion
Forecast Year [2032] USD 129.85 billion
CAGR (%) 10.59%

A clear and strategic orientation to the evolving urology device landscape driven by demographic shifts, clinical practice change, and accelerating technological innovation

The urology device landscape is being reshaped by converging clinical needs, demographic trends, and rapid technological innovation. Aging populations are increasing the prevalence of chronic and acute urological conditions, while care-delivery models are shifting procedures from inpatient to ambulatory settings. In parallel, advances in imaging and minimally invasive tools are changing clinical pathways and clinician expectations, prompting providers to reassess capital allocation and procurement strategies.

Consequently, manufacturers, distributors, and health systems are navigating a more complex environment where regulatory scrutiny, infection-prevention priorities, and sustainability considerations intersect. Payers and providers seek value through outcome-driven procurement and long-term service relationships, and digital channels are beginning to alter traditional distribution dynamics. Taken together, these forces demand strategic clarity about product portfolios, channel investments, and partnerships that can sustain clinical relevance and commercial performance amid accelerating change.

How minimally invasive techniques, imaging advances, single-use adoption and digital distribution are fundamentally reshaping clinical practice and commercial models in urology

Over recent years the industry has experienced transformative shifts that are redefining product lifecycles, procurement practices, and patient pathways. Minimally invasive techniques, fueled by refined imaging and laser technology, are lowering thresholds for procedural intervention and shortening length of stay, which in turn supports the continued migration of procedures to ambulatory surgical centers and outpatient clinics. Simultaneously, the adoption of single-use disposable devices has accelerated, driven by infection-control priorities, operational simplicity, and changes in total cost-of-care calculations.

At the same time, digital integration and advanced imaging modalities are enabling earlier diagnosis and more precise interventions, while artificial intelligence and enhanced visualization tools are beginning to influence device design and clinical workflows. Distribution channels are adapting as e-commerce and direct-to-provider models gain traction alongside traditional hospital procurement, creating new competitive pressures and pricing dynamics. As these shifts continue, companies that integrate cross-functional expertise-combining device innovation, service delivery, and data-driven clinical evidence-will be better positioned to capture opportunities and mitigate the operational and regulatory headwinds that accompany rapid sector transformation.

Assessing the wide-ranging operational and strategic consequences of United States tariff actions in 2025 on sourcing, production, procurement and pricing dynamics across urology devices

The cumulative effects of tariff changes implemented in 2025 in the United States have created a new set of constraints and incentives across the urology device supply chain. Manufacturers reliant on imported components have faced increased input costs, prompting many to reassess sourcing strategies and accelerate initiatives to regionalize production or qualify alternative suppliers. These adjustments have affected pricing strategies, inventory policies, and supplier contracts, leading stakeholders to re-evaluate long-term supplier relationships and contractual flexibility.

Healthcare providers and distributors have responded by intensifying negotiations, prioritizing value-based purchasing, and increasing scrutiny of total cost implications, including service and consumable components. In addition, some device makers have shifted higher-value assembly and final testing to domestic facilities to reduce exposure to tariff volatility and to maintain more predictable lead times. Regulatory compliance and customs complexity have added administrative burdens, which in turn favor larger organizations with robust supply-chain functions. Overall, the tariff environment has accelerated structural adjustments in sourcing, production footprints, and commercial terms, prompting both near-term operational responses and longer-term strategic repositioning among manufacturers and purchasers.

Deep segmentation framework highlighting product, application, end-user, channel and technology distinctions that drive clinical utility, procurement behavior and commercial strategy

A granular view of segmentation reveals differentiated demand, clinical utility, and procurement behavior across product, application, end-user, distribution, and technology dimensions. By product type, the landscape separates into disposable devices and reusable devices, where disposable devices encompass catheters and stents; catheters further segment into Foley catheters and intermittent catheters while stents further divide into nephrostomy stents and ureteral stents. Reusable devices include endoscopes and surgical instruments, and endoscopes can be further categorized into flexible endoscopes and rigid endoscopes. These product distinctions correlate strongly with infection-control priorities, procedure volumes, and capital-investment cycles.

Applications map to distinct clinical drivers including benign prostatic hyperplasia treatment, cancer diagnosis, stone removal, and urinary incontinence management, each of which has specific clinical workflows, reimbursement considerations, and device-performance requirements. End users vary among ambulatory surgical centers, clinics, and hospitals, and each setting has unique procurement governance, budget horizons, and operational constraints. Distribution channels range across e-commerce, hospital purchases, and retail pharmacies, with digital channels progressively influencing purchasing behaviors for consumables and smaller devices. Technology segmentation encompasses imaging technology and laser technology; imaging technology itself spans CT scan, MRI, and ultrasound modalities, which inform diagnostic pathways and procedural planning. Understanding these intersecting segments enables targeted product development, differentiated sales strategies, and service models tailored to clinical needs and buyer preferences.

Regional dynamics across Americas, Europe, Middle East & Africa and Asia-Pacific shaping procurement, regulatory engagement, and supply-chain resilience for urology devices

Regional dynamics are shaping competitive priorities and investment choices across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct regulatory, reimbursement, and supply-chain contexts. In the Americas, a mix of private providers, consolidated hospital systems, and an expanding ambulatory surgical center footprint have heightened demand for devices that reduce procedure time and support same-day discharge, while distribution models reflect growing adoption of direct procurement and e-commerce for consumables.

Across Europe, the Middle East & Africa, procurement is often influenced by public payers and centralized purchasing mechanisms; cost-containment pressures coexist with a high bar for clinical evidence and reprocessing standards, which sustains the relevance of reusable equipment in some markets. In the Asia-Pacific region, rapid healthcare investment, expanding procedural volumes, and a focus on local manufacturing capacity are accelerating adoption of minimally invasive technologies, imaging upgrades, and hybrid distribution strategies. These regional distinctions imply that commercial tactics should be localized, regulatory engagement must be proactive, and supply-chain resilience tailored to each region's mix of regulatory complexity, procurement maturity, and infrastructure development.

Industry competitive dynamics driven by strategic partnerships, service-led offerings, and consolidation as players prioritize integrated solutions, aftersales and scalability

Competitive dynamics within the urology device ecosystem are increasingly characterized by strategic diversification, partnerships, and service-oriented business models. Leading manufacturers are investing in bundled solutions that combine devices with training, data services, and maintenance agreements to deepen customer relationships and create recurring revenue streams. Strategic collaborations between device makers, imaging providers, and clinical centers are accelerating validation cycles and supporting broader adoption of integrated procedural solutions.

At the same time, smaller innovators are focusing on niche indications, disposable alternatives, and technology-enabled differentiation to gain clinical traction and attract distribution partners. Consolidation activity continues as companies seek scale in manufacturing, regulatory expertise, and aftermarket service capabilities, while contract terms and service-level commitments have become central considerations in procurement decisions. In this environment, companies that align R&D priorities with clear clinical value propositions and robust post-sale support will be better positioned to secure durable contracts and navigate evolving reimbursement and procurement pressures.

Practical, high-impact actions for industry leaders to strengthen supply chains, differentiate clinically, and expand service-oriented commercial models to secure durable growth

To navigate the evolving landscape and capture sustainable growth, industry leaders should pursue a combination of supply-chain resilience, clinical differentiation, and commercial agility. First, diversifying supplier bases and regionalizing critical manufacturing steps reduces exposure to tariff volatility and protects lead times, while investments in inventory visibility and flexible contract terms improve operational resilience. Second, prioritizing product features that demonstrate measurable clinical and economic benefits-such as reduced procedure time, lower infection risk, or decreased total episode cost-will enhance procurement positioning with value-minded buyers.

Third, building service and training packages that accompany device sales increases customer retention and creates predictable revenue streams, particularly for providers shifting procedures to outpatient settings. Fourth, expanding digital and direct-to-provider distribution channels for consumables and lower-cost devices complements traditional hospital purchasing and enables faster market access. Finally, engaging proactively with regulators and payers to communicate clinical evidence and real-world outcomes will support favorable adoption and reimbursement decisions. Executed together, these actions create a defensible strategic posture grounded in operational reliability, clinical relevance, and commercial flexibility.

Robust, multi-method research methodology combining clinical literature, regulatory review, expert interviews and validation to produce actionable and verifiable industry insights

The research approach combined multi-disciplinary inputs to ensure analytical rigor, triangulation, and practical relevance. Secondary research involved systematic review of peer-reviewed clinical literature, regulatory filings, procedural guidelines, and public policy documents to map clinical pathways, technology adoption, and compliance requirements. Primary research included structured interviews with clinicians, procurement leaders, supply-chain managers, and product developers to capture real-world operational constraints, preference drivers, and adoption barriers. Data from manufacturer technical documentation and product registries informed device specifications and functional comparisons.

Qualitative insights were validated against purchaser procurement frameworks and clinical experts to ensure alignment with practice patterns and purchasing rationales. The methodology prioritized transparency in assumptions, explicit documentation of data sources, and a layered validation process comprising internal cross-functional review and external expert validation. Limitations include variability in institutional procurement practices and the evolving nature of tariffs and regulatory guidance, which were addressed through sensitivity analyses and scenario planning to illuminate plausible strategic responses rather than singular deterministic outcomes.

Concluding synthesis of strategic priorities and urgent actions required to translate technological advances and supply-chain challenges into competitive advantage in urology

In summary, the urology device environment is at an inflection point where clinical innovation, procurement evolution, and supply-chain pressures intersect. The shift toward minimally invasive techniques, the rise of disposable options for infection control, and the integration of advanced imaging and laser technologies are reshaping clinical pathways and buyer expectations. Concurrently, tariff-driven cost dynamics and regional variations in procurement and regulatory regimes require companies to be nimble in sourcing, pricing, and commercial engagement.

Looking forward, success will depend on an integrated approach that aligns product development with clear clinical value, reinforces service and training capabilities, and builds supply-chain resilience. Providers and manufacturers who proactively adapt to outpatient migration, invest in digital and distribution flexibility, and collaborate across clinical, regulatory, and commercial functions will be better positioned to deliver improved patient outcomes while maintaining financial and operational stability. The time to act is immediate, as strategic choices made now will determine who captures advantage as the landscape continues to evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rise of robotic-assisted laparoscopic surgeries for prostate and kidney procedures driven by technological advances and patient demand
  • 5.2. Development and adoption of non-invasive biomarkers for early detection of prostate cancer to improve patient outcomes
  • 5.3. Growth in minimally invasive therapies for benign prostatic hyperplasia like prostate artery embolization and water vapor therapy
  • 5.4. Integration of telemedicine and remote patient monitoring platforms for post-surgical care in urology practices across regions
  • 5.5. Surge in targeted therapies and immunotherapy combinations for advanced urothelial carcinoma based on precision medicine approaches
  • 5.6. Adoption of AI-powered diagnostic imaging analysis to enhance accuracy and efficiency in urologic disease detection

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urology Market, by Product Type

  • 8.1. Disposable Devices
    • 8.1.1. Catheters
      • 8.1.1.1. Foley Catheters
      • 8.1.1.2. Intermittent Catheters
    • 8.1.2. Stents
      • 8.1.2.1. Nephrostomy Stents
      • 8.1.2.2. Ureteral Stents
  • 8.2. Reusable Devices
    • 8.2.1. Endoscopes
      • 8.2.1.1. Flexible Endoscopes
      • 8.2.1.2. Rigid Endoscopes
    • 8.2.2. Surgical Instruments

9. Urology Market, by Application

  • 9.1. Benign Prostatic Hyperplasia Treatment
  • 9.2. Cancer Diagnosis
  • 9.3. Stone Removal
  • 9.4. Urinary Incontinence Management

10. Urology Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Urology Market, by Distribution Channel

  • 11.1. E-Commerce
  • 11.2. Hospital Purchases
  • 11.3. Retail Pharmacies

12. Urology Market, by Technology

  • 12.1. Imaging Technology
    • 12.1.1. CT Scan
    • 12.1.2. MRI
    • 12.1.3. Ultrasound
  • 12.2. Laser Technology

13. Urology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Urology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Urology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Boston Scientific Corporation
    • 16.3.2. Johnson & Johnson
    • 16.3.3. Olympus Corporation
    • 16.3.4. Medtronic plc
    • 16.3.5. Stryker Corporation
    • 16.3.6. Coloplast A/S
    • 16.3.7. Teleflex Incorporated
    • 16.3.8. Becton, Dickinson and Company
    • 16.3.9. STERIS plc
    • 16.3.10. Baxter International Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL UROLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL UROLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLOGY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL UROLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL UROLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL UROLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS UROLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL UROLOGY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. UROLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. UROLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UROLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UROLOGY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL UROLOGY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL UROLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL UROLOGY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS UROLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS UROLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 321. MIDDLE EAST UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 322. MIDDLE EAST UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 324. MIDDLE EAST UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 325. MIDDLE EAST UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. MIDDLE EAST UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. MIDDLE EAST UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. MIDDLE EAST UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. MIDDLE EAST UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 330. MIDDLE EAST UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 331. MIDDLE EAST UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 332. MIDDLE EAST UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 333. MIDDLE EAST UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 334. MIDDLE EAST UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 335. AFRICA UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 336. AFRICA UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 337. AFRICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. AFRICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. AFRICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 340. AFRICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 341. AFRICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 342. AFRICA UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 343. AFRICA UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 344. AFRICA UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 345. AFRICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 346. AFRICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 347. AFRICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 348. AFRICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 349. AFRICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 350. AFRICA UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 351. AFRICA UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 352. AFRICA UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 353. AFRICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 354. AFRICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 355. AFRICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 356. AFRICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 357. AFRICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 358. AFRICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 359. ASIA-PACIFIC UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 360. ASIA-PACIFIC UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 361. ASIA-PACIFIC UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 362. ASIA-PACIFIC UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 363. ASIA-PACIFIC UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 364. ASIA-PACIFIC UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 365. ASIA-PACIFIC UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 366. ASIA-PACIFIC UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 367. ASIA-PACIFIC UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 368. ASIA-PACIFIC UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 369. ASIA-PACIFIC UROLOGY MARKET S